When you see weight loss in a cat with chronic kidney disease (CKD), think Elura.
Elura is a first-in-class ghrelin receptor agonist, providing a novel mechanism of action to address weight loss in cats with CKD. It binds to receptors in the hypothalamus to stimulate appetite and in the pituitary to stimulate secretion of growth hormone (GH). Weight gain in cats taking Elura is thought to be due to a combination of increased food intake and metabolic changes.
Elura helps cats with CKD gain weight
It can be hard to watch cats with CKD waste away. Weight loss in cats with CKD has already started in most cats by the time of diagnosis, accelerates as the disease progresses and is associated with shorter survivial2. Prescribe Elura at the first sign of weight loss to help your feline CKD patients gain weight and stay their fabulous selves.
Why Elura?
- Safe to use daily
- Approved for long-term use
- Once-daily, flavored oral solution
- More than 8/10 cats gained weight1*
- Specifically approved for use in cats with CKD
Indication
Elura is indicated for the management of weight loss in cats with chronic kidney disease.
Important Safety Information
For oral use in cats only. Do not use in cats that have a hypersensitivity to capromorelin, or in cats with hypersomatotropism (acromegaly). Elura may increase serum glucose for several hours after dosing; use in cats with current or historical diabetes mellitus has not been evaluated and may not be appropriate. Use with caution in cats that may have cardiac disease, severe dehydration, or hepatic dysfunction. Elura has not been evaluated in cats younger than 5 months of age, or in breeding, pregnant or lactating cats. The most common adverse reactions included vomiting, hypersalivation, inappetence, behavior change and lethargy. Please see Elura product label for full Prescribing Information.
